Zobrazeno 1 - 10
of 1 780
pro vyhledávání: '"programmed cell death protein 1"'
Publikováno v:
Parasites & Vectors, Vol 17, Iss 1, Pp 1-12 (2024)
Abstract Background Alveolar echinococcosis (AE), a fatal disease caused by Echinococcus multilocularis, often affects the liver, with tumor-like growth. However, the mechanism by which E. multilocularis evades host immune surveillance remains unclea
Externí odkaz:
https://doaj.org/article/132b5309919b4b5db3746b728d035400
Publikováno v:
Journal of Hepatocellular Carcinoma, Vol Volume 11, Pp 1961-1978 (2024)
Fengtao Zhang,1,* Sheng Zhong,2,* Qiming Wei,3 Haiming Zhang,4 Honglei Hu,5 Bicheng Zeng,6 Xiang Zheng7 1Vascular Interventional Surgery, Huazhong University of Science and Technology Union Shenzhen Hospital(Shenzhen Nanshan People’s Hospit
Externí odkaz:
https://doaj.org/article/b21313dcd51546379e073df1053e484a
Publikováno v:
Journal of Cardiothoracic Surgery, Vol 19, Iss 1, Pp 1-7 (2024)
Abstract Objective This study aims to compare the perioperative outcomes and disease-free survival (DFS) between pneumonectomy after immunochemotherapy and chemotherapy. Methods We retrospectively identified patients who received neoadjuvant immunoth
Externí odkaz:
https://doaj.org/article/0388bef6ceb74ba1ab6846d344a65805
Autor:
Aseel S. Mahmood
Publikováno v:
Journal of Advanced Pharmaceutical Technology & Research, Vol 15, Iss 3, Pp 225-230 (2024)
PD-1 has a noteworthy function in developing acute myeloid leukemia (AML). The expression of PD-1 on effector T cells is regulated at the protein level depending on the interactions between cells. The objective of the study was to evaluate the PD-1 c
Externí odkaz:
https://doaj.org/article/fdd156cf97a44b60946369b2bfa22eeb
Autor:
Jian Zhang, Aiqin Gao, Shuyun Wang, Yanxin Sun, Jiake Wu, Dahai Wang, Yihui Ge, Juan Li, Haifeng Sun, Qinglei Cheng, Yuping Sun
Publikováno v:
Respiratory Research, Vol 25, Iss 1, Pp 1-8 (2024)
Abstract Background Patients receiving PD-(L)1 inhibitors frequently encounter unusual side effects known as immune-related adverse events (irAEs). However, the correlation of irAEs development with clinical response in small cell lung cancer (SCLC)
Externí odkaz:
https://doaj.org/article/81edf98278c9466d9563b891d6a4d6fb
Autor:
Zhitao Dong, Chengjun Sui, Jiongjiong Lu, Junwu Guo, Kecai Duan, Kui Wang, Li Geng, Binghua Dai, Jiamei Yang
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundCurrently, the prognosis of advanced intrahepatic cholangiocarcinoma (ICC) is poor, and the current treatment methods are not effective.ObjectiveThe aim of this study was to evaluate the anticancer efficacy of chemotherapy combined with PD-
Externí odkaz:
https://doaj.org/article/08d8de606c4b4a05af116d358e57739d
Publikováno v:
Journal of Hepatocellular Carcinoma, Vol Volume 11, Pp 619-628 (2024)
Xiaochen Ma, Xiangyang Sun, Fubo Xie, Wencheng Jian, Qingliang Wang, Yang Xie, Caixia Li, Kai Zhang Department of Radiology, Qilu Hospital of Shandong University, Jinan, Shandong, People’s Republic of ChinaCorrespondence: Kai Zhang, Department of R
Externí odkaz:
https://doaj.org/article/afe5901930e24292bd9ae99b4f39d460
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundImmune checkpoint blockade (ICB)-based immunotherapy has inspired new hope for advanced biliary tract cancer (BTC) treatment; however, there are no prior studies that primarily focus on different anatomical types of unresectable BTCs reacti
Externí odkaz:
https://doaj.org/article/cbb3dfc762cd498b8c0f92574dee7e71
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
ObjectiveTo evaluate the efficacy and safety of PD-1/L1 inhibitors as first-line therapy in metastatic colorectal cancer(mCRC).MethodArticles evaluating first-line PD-1/L1 inhibitors for mCRC were sought in four databases (Pubmed, Embase, Web of Scie
Externí odkaz:
https://doaj.org/article/f34c6af4806e423f9458e09677bb4959
Publikováno v:
Biomolecules & Biomedicine (2024)
The application of immune checkpoint inhibitors has proven to be an effective treatment for cancer. Immune checkpoints such as programmed cell death protein 1/programmed cell death protein 1 ligand 1 (PD-1/PD-L1), cytotoxic T-lymphocyte-associated pr
Externí odkaz:
https://doaj.org/article/07da0ce7416b417baaa5e1cbbf0deb18